Found: 111
Select item for more details and to access through your institution.
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
- Published in:
- Liver International, 2013, v. 33, n. 10, p. 1594, doi. 10.1111/liv.12199
- By:
- Publication type:
- Article
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA. LI. CA centres.
- Published in:
- Liver International, 2013, v. 33, n. 9, p. 1420, doi. 10.1111/liv.12208
- By:
- Publication type:
- Article
Platelet count manipulation and modification of global haemostasis tests in patients with chronic liver disease: almost there, almost there...
- Published in:
- Liver International, 2013, v. 33, n. 3, p. 325, doi. 10.1111/liv.12105
- By:
- Publication type:
- Article
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.
- Published in:
- Liver International, 2012, v. 32, n. 7, p. 1113, doi. 10.1111/j.1478-3231.2012.02798.x
- By:
- Publication type:
- Article
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study.
- Published in:
- Liver International, 2011, v. 31, n. 2, p. 192, doi. 10.1111/j.1478-3231.2010.02409.x
- By:
- Publication type:
- Article
Transarterial chemoembolization in Child–Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: Clinical considerations and disease burden.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 11, p. 1882, doi. 10.1002/jmv.21523
- By:
- Publication type:
- Article
Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go... Authors' reply'.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Applying Lyon consensus criteria in the work‐up of patients with extra‐oesophageal symptoms – A multicentre retrospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 9, p. 1134, doi. 10.1111/apt.17934
- By:
- Publication type:
- Article
Letter: predictive factors for treatment discontinuation in IBD—anti‐TNF trough levels and anti‐drug antibodies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 4, p. 536, doi. 10.1111/apt.16494
- By:
- Publication type:
- Article
Letter: vedolizumab or a second anti‐TNF—no difference in efficacy for primary biologic failures with IBD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 9, p. 1044, doi. 10.1111/apt.16301
- By:
- Publication type:
- Article
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)
- Published in:
- Infection, 2019, v. 47, n. 1, p. 141, doi. 10.1007/s15010-018-1209-2
- By:
- Publication type:
- Article
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
- Published in:
- Infection, 2018, v. 46, n. 5, p. 607, doi. 10.1007/s15010-018-1157-x
- By:
- Publication type:
- Article
Feasibility of the Cut-and-Push Method for Removing Large-Caliber Soft Percutaneous Endoscopic Gastrostomy Devices.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A Review on the Use of Eltrombopag in Patients with Advanced Liver Disease.
- Published in:
- Clinical Medicine: Therapeutics, 2009, n. 1, p. 1489, doi. 10.4137/CMT.S2267
- By:
- Publication type:
- Article
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 15, p. 3201, doi. 10.3390/jcm10153201
- By:
- Publication type:
- Article
Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4254, doi. 10.3390/cancers14174254
- By:
- Publication type:
- Article
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1673, doi. 10.3390/cancers13071673
- By:
- Publication type:
- Article
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 897, doi. 10.3390/cancers13040897
- By:
- Publication type:
- Article
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 592, doi. 10.3390/cancers13040592
- By:
- Publication type:
- Article
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1422, doi. 10.3390/cancers12061422
- By:
- Publication type:
- Article
Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1689, doi. 10.3390/cancers11111689
- By:
- Publication type:
- Article
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1568, doi. 10.3390/cancers11101568
- By:
- Publication type:
- Article
Transition Programmes for Young Patients with Inflammatory Bowel Disease Improve Adherence to Care.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.
- Published in:
- Liver International, 2024, v. 44, n. 7, p. 1588, doi. 10.1111/liv.15855
- By:
- Publication type:
- Article
May we actually help clinicians select the best systemic treatment for patients with intermediate-stage hepatocellular carcinoma?
- Published in:
- Liver International, 2024, v. 44, n. 2, p. 272, doi. 10.1111/liv.15781
- By:
- Publication type:
- Article
Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta‐analysis.
- Published in:
- Liver International, 2023, v. 43, n. 7, p. 1399, doi. 10.1111/liv.15609
- By:
- Publication type:
- Article
Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 258, doi. 10.1111/liv.15482
- By:
- Publication type:
- Article
Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 8, doi. 10.1111/liv.15419
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. i, doi. 10.1111/liv.15484
- By:
- Publication type:
- Article
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2607, doi. 10.1111/liv.15432
- By:
- Publication type:
- Article
The changing scenario of hepatocellular carcinoma in Italy: an update.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 585, doi. 10.1111/liv.14735
- By:
- Publication type:
- Article
Monofocal hepatocellular carcinoma: How much does size matter?
- Published in:
- Liver International, 2021, v. 41, n. 2, p. 396, doi. 10.1111/liv.14718
- By:
- Publication type:
- Article
COVID‐19 and liver disease: Not all evil comes to harm.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 237, doi. 10.1111/liv.14721
- By:
- Publication type:
- Article
Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 530, doi. 10.1111/liv.14250
- By:
- Publication type:
- Article
Hepatitis C virus therapy in children: No one should be left behind.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 283, doi. 10.1111/liv.14331
- By:
- Publication type:
- Article
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1478, doi. 10.1111/liv.14154
- By:
- Publication type:
- Article
Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: The perfect storm.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Metabolic disorders across hepatocellular carcinoma in Italy.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2028, doi. 10.1111/liv.13877
- By:
- Publication type:
- Article
Specific issues concerning the management of patients on the waiting list and after liver transplantation.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1338, doi. 10.1111/liv.13755
- By:
- Publication type:
- Article
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
- Published in:
- Liver International, 2017, v. 37, n. 3, p. 423, doi. 10.1111/liv.13242
- By:
- Publication type:
- Article
The evolutionary scenario of hepatocellular carcinoma in Italy: an update.
- Published in:
- Liver International, 2017, v. 37, n. 2, p. 259, doi. 10.1111/liv.13204
- By:
- Publication type:
- Article
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
- Published in:
- Liver International, 2015, v. 35, n. 1, p. 223, doi. 10.1111/liv.12649
- By:
- Publication type:
- Article
Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 235, doi. 10.1159/000533991
- By:
- Publication type:
- Article
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 126, doi. 10.1159/000513404
- By:
- Publication type:
- Article
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.822507
- By:
- Publication type:
- Article
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 6, p. 1, doi. 10.1111/eci.14143
- By:
- Publication type:
- Article
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma.
- Published in:
- European Journal of Clinical Investigation, 2023, v. 53, n. 1, p. 1, doi. 10.1111/eci.13870
- By:
- Publication type:
- Article
Is there an 'ideal' diet for patients with NAFLD?
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 3, p. 1, doi. 10.1111/eci.13659
- By:
- Publication type:
- Article
Efficacy of 48-hour Post-operative Antibiotics Prophylaxis for Patients Undergoing Percutaneous Endoscopic Gastrostomy Tube in Preventing Site Infection.
- Published in:
- Journal of Gastrointestinal & Liver Diseases, 2011, v. 20, n. 2, p. 131
- By:
- Publication type:
- Article